Publications by authors named "Sahar Farshchi Tabrizi"
Clin Case Rep
August 2024
Article Synopsis
- Patients on anti-TNF-α drugs for ankylosing spondylitis (AS) should be closely monitored for symptoms like purpuric and ischemic skin lesions to catch potential drug-induced issues early.
- A case study highlighted a 38-year-old woman who developed skin lesions after starting adalimumab, leading to a diagnosis of vasculitis linked to the medication.
- Stopping adalimumab and switching to other treatments like glucocorticoids and cyclophosphamide successfully resolved her skin issues, emphasizing the need to be aware of medication side effects in AS patients.
